|
The FLEX real-world data platform explores new gene expression profiles and investigator-initiated protocols in early stage breast cancer. |
|
|
Travel, Accommodations, Expenses - Agendia |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Agendia; Bayer; Bioarray Therapeutics; bioTheranostics; Celgene; Eisai; Genentech/Roche; Genomic Health; Lilly; Merck; Myriad Pharmaceuticals; NanoString Technologies; Novartis; Pfizer; Puma Biotechnology |
|
|
Stock and Other Ownership Interests - QView Medical |
Honoraria - Bard Medical; GE Healthcare |
Speakers' Bureau - Bard Medical; GE Healthcare |
Research Funding - GE Healthcare |
|
|
Stock and Other Ownership Interests - Bluebird Bio; Conatus; Immunogen; Immunomedics; Novocure; Viking Medical |
Honoraria - Agendia; AstraZeneca; Genomic Health; Lilly; Myriad Genetics; Novartis; Pfizer |
Consulting or Advisory Role - Agendia; Genentech; Genomic Health; Lilly; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology |
Speakers' Bureau - Agendia; Genentech; Genomic Health; Lilly; Novartis; Pfizer; Puma Biotechnology |
Research Funding - Pfizer (Inst); Seagen (Inst) |
Travel, Accommodations, Expenses - Genentech; Lilly; Novartis; Pfizer |
|
|
Consulting or Advisory Role - Athenex; Celgene; Janssen |
Travel, Accommodations, Expenses - Agendia |
|
|
No Relationships to Disclose |
|
Rakhshanda Layeequr Rahman |
Travel, Accommodations, Expenses - Agendia |
|
|
Travel, Accommodations, Expenses - Agendia |
|
|
Leadership - SEngine Precision Medicine |
Stock and Other Ownership Interests - Sengine precision medicine |
Consulting or Advisory Role - bioTheranostics; Novartis; Puma Biotechnology; Seagen |
Research Funding - Agendia; Genentech/Roche (Inst); SignalOne Bio |
|
|
|
|
|
|
Stock and Other Ownership Interests - Agendia |
|
|
|
|
|
|
|
|
No Relationships to Disclose |